ImmuCell Corp (ICCC)
5.10
+0.06
(+1.19%)
USD |
NASDAQ |
Apr 25, 16:00
5.04
-0.06
(-1.18%)
After-Hours: 20:00
ImmuCell Profit Margin (Quarterly): -22.37% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -22.37% |
| September 30, 2023 | -17.42% |
| June 30, 2023 | -39.06% |
| March 31, 2023 | -67.17% |
| December 31, 2022 | -42.65% |
| September 30, 2022 | -13.66% |
| June 30, 2022 | -17.72% |
| March 31, 2022 | 8.56% |
| December 31, 2021 | 1.36% |
| September 30, 2021 | 2.87% |
| June 30, 2021 | 3.11% |
| March 31, 2021 | -10.74% |
| December 31, 2020 | 5.04% |
| September 30, 2020 | -8.67% |
| June 30, 2020 | -25.82% |
| March 31, 2020 | -2.49% |
| December 31, 2019 | -8.55% |
| September 30, 2019 | -16.92% |
| June 30, 2019 | -23.14% |
| March 31, 2019 | 3.28% |
| December 31, 2018 | -35.83% |
| September 30, 2018 | -11.61% |
| June 30, 2018 | -26.48% |
| March 31, 2018 | -7.67% |
| December 31, 2017 | -6.21% |
| Date | Value |
|---|---|
| September 30, 2017 | -16.93% |
| June 30, 2017 | -12.48% |
| March 31, 2017 | 16.49% |
| December 31, 2016 | 1.37% |
| September 30, 2016 | 1.77% |
| June 30, 2016 | -0.39% |
| March 31, 2016 | 15.15% |
| December 31, 2015 | 10.72% |
| September 30, 2015 | 14.21% |
| June 30, 2015 | 4.80% |
| March 31, 2015 | 15.45% |
| December 31, 2014 | 5.92% |
| September 30, 2014 | 0.58% |
| June 30, 2014 | -19.15% |
| March 31, 2014 | -0.64% |
| December 31, 2013 | -9.67% |
| September 30, 2013 | 4.64% |
| June 30, 2013 | 0.47% |
| March 31, 2013 | 11.06% |
| December 31, 2012 | -1.19% |
| September 30, 2012 | -5.90% |
| June 30, 2012 | 1.29% |
| March 31, 2012 | 9.01% |
| December 31, 2011 | -0.04% |
| September 30, 2011 | -12.72% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-67.17%
Minimum
Mar 2023
8.56%
Maximum
Mar 2022
-15.55%
Average
-13.66%
Median
Sep 2022
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -21.17% |
| Return on Assets | -13.10% |
| Return on Invested Capital | -14.99% |
| Gross Profit Margin (Quarterly) | 24.68% |
| Operating Margin (Quarterly) | -19.69% |
| Return on Net Operating Assets | -13.97% |